Effect of immune checkpoint inhibitors in gynecologic cancer associated with defective mismatch repair and a rare immunotherapy-related adverse event. J Cancer Res Pract 2021;8:73-7. doi: 10.4103/JCRP.JCRP_4_21
Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice. Front. Oncol. 10:584834. doi: 10.3389/fonc.2020.584834
